Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Nanomedicine: Nanotechnology, Biology, and Medicine is Scopus-indexed (Q1, CiteScore 10.3), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Inc..
Checked against the index lists dated .
ISSN 1549-9634Verify ISSN ↗1549-9642Verify ISSN ↗
Publisher: Elsevier Inc.
Cost to publish: About US$3,670 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 41 / 466 | 91st | Q1 |
| Pharmaceutical Science | 23 / 191 | 88th | Q1 |
| Materials Science (all) | 71 / 475 | 85th | Q1 |
| Molecular Medicine | 30 / 179 | 83rd | Q1 |
| Biomedical Engineering | 60 / 342 | 82nd | Q1 |
| Bioengineering | 32 / 168 | 81st | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2005–present, best quartile Q1, CiteScore 10.3.
Nanomedicine: Nanotechnology, Biology, and Medicine is Q1 in Medicine (miscellaneous) (rank 41 of 466), Q1 in Pharmaceutical Science (rank 23 of 191) and Q1 in Materials Science (all) (rank 71 of 475), by CiteScore 2025. It is ranked in 6 subject areas in all.
Nanomedicine: Nanotechnology, Biology, and Medicine is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 10.3, which places it in quartile Q1 at the 91st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.845, quartile Q1, with an H-index of 166.
The publisher lists an article processing charge of about US$3,670 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Nanomedicine: Nanotechnology, Biology, and Medicine is published by Elsevier Inc. Its print ISSN is 1549-9634 and its online ISSN is 1549-9642.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Nanomedicine: Nanotechnology, Biology, and Medicine has an h-index of 173 and a 2-year mean of 2.09 citations per paper (OpenAlex). Its Scopus CiteScore is 10.3, quartile Q1. On 2-year citations it ranks #159 of 451 Scopus journals in Medicine (miscellaneous).
Nanomedicine: Nanotechnology, Biology, and Medicine published 92 papers in 2025; its busiest recent year was 2018 with 562. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from China (38.3%), India (22.4%) and United States (6.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 5 retracted papers are recorded (1.2 per 1,000 papers). The Problematic Paper Screener flags 2 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.